MadeMed Tirzepatide Review: Charges, Supply and Refunds

MadeMed lists compounded tirzepatide injection and sublingual tablets at $249 every 30 days, $672 every 90 days, or $2,390 every 360 days. The lower monthly figures are equivalents for longer payment periods. A separate consultation costs $20 asynchronously or $30 for a video visit; it is charged even when no prescription is issued.^5,6

The useful disclosure is the amount charged and the fulfillment schedule. The important limit is that cancellation stops future renewal rather than creating a refund for an unused portion of the paid term. Compare the actual charge, consultation fee and supply before choosing the longest plan.⁷

Three payment periods, not three monthly bills

The injection page's default 90-day selection shows $672 due, an effective $224 per month and three shipments per charge. Selecting 30 days shows $249 and one shipment; selecting 360 days shows $2,390 and twelve shipments. The annual equivalent is approximately $199.17, rounded to $199 in the comparison table. Neither lower equivalent is the flexible 30-day charge.⁵

Both routes advertise the same medication prices and no dose surcharges. The $20/$30 consultation is separately listed across the plans, while ongoing clinician messaging is included. “All doses included” does not make the initial consultation free, and a flat medication price should not be described as an all-inclusive care total.^5,6

For a comparison with Actin or Rese Wellness, match the payment period, medication supply, included clinical work and cancellation exposure. Dividing a prepaid charge into monthly equivalents does not make unused months refundable.

Injection and sublingual fulfillment differ

The injection is described as tirzepatide with pyridoxine, or vitamin B6. Supplies, shipping and continuing clinical messaging are included, but confirm the actual vial concentration, quantity, storage instructions and replacement schedule with the dispensing pharmacist. An added ingredient does not establish superior effectiveness, fewer adverse effects or equivalence to an approved branded preparation.⁵

FDA recommends discarding compounded GLP-1 multidose vials within 28 days after first use, even when a compounder's instructions allow longer. Ask how each shipment is divided into vials and how the pharmacist's supplied quantity and instructions fit that recommendation. A shipment count alone does not establish how long an opened vial should be used.⁴

The sublingual page names a 3 mg tablet and the same 30-, 90- and 360-day charges. Its default 90-day selection shows one shipment per charge; its comparison table shows four shipments for the 360-day plan. The FAQ also describes a 30-day tablet supply. Confirm the exact quantity and refill arrangement for your prescribed plan rather than assuming it matches the injection schedule.⁶

An oral compound is not interchangeable with injectable Zepbound. A published tablet dose and a weekly injection dose cannot be compared milligram for milligram, and injectable clinical-trial results do not establish the tablet's absorption or outcomes. Read our oral tirzepatide guide before choosing on needle avoidance alone.

Who provides care and fills prescriptions?

The October 9 Terms name IDL Health LLC, doing business as MadeMed, as the platform operator and MDI Medical Group PC and affiliated providers as the independent clinical group. They list Absolute RX, Strive Pharmacy, ERX Hub and Southend Pharmacy as pharmacy partners. A network list is not confirmation of the pharmacy assigned to a particular prescription.⁷

The product pages describe 503A preparation and display certification and quality badges. These are company-published claims, not independent verification of a facility's licensing, certification or the contents of a future prescription. Confirm the preparing and dispensing pharmacy and its prescription-specific instructions.^5,6

The oral FAQ lists 40-state availability, excluding Alabama, Alaska, Arkansas, Hawaii, Massachusetts, Missouri, New Mexico, New York, South Carolina and Virginia. The Terms make service availability conditional on state law. Do not apply the oral page's state list automatically to every MadeMed medication or assume broad nationwide marketing guarantees access.^6,7

Cancellation and a declined prescription have different outcomes

The Terms authorize recurring charges, with 30- or 90-day cycles given as examples, until cancellation. Cancellation through the portal or support email becomes effective at the end of the current billing period, with no prorated refund. The product FAQ says renewals are notified in advance and describes pause, skip and cancel options. Confirm the next charge date and whether an order is already being fulfilled.^5,7

If the clinician does not prescribe, the product pages promise to refund the medication charge while retaining the $20 or $30 consultation fee. The November 1, 2025 returns policy separately makes completed consultations nonrefundable and prescription and OTC product sales final. That combination is not a money-back trial after medication is dispensed.^3,5,6

Consultation cancellation or rescheduling requires at least 24 hours' notice; later cancellation may not qualify for a refund. Damaged, incorrect or lost orders must be reported promptly, with the policy specifying notice within seven days of delivery. Replacement or a refund of the affected product is discretionary under those provisions, not a universal refund guarantee.³

Where MadeMed fits

MadeMed now publishes distinct payment totals and separates its initial consultation fee. The remaining decision is whether the longer commitment and route-specific supply suit your clinical plan. Neither the sublingual tablet nor the B6 injection should inherit branded trial outcomes solely from sharing an ingredient name.

For a branded pathway, compare Ro and the Zepbound cost guide. Keep medication, consultation and renewal costs separate when comparing the final amount at risk.